(Q577387)

41859-67-0 (English)

19 October 2016

C₁₉H₂₀ClNO₄

1 reference

41859-67-0 (English)

19 November 2016

CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl

1 reference

https://www.whocc.no/atc_ddd_index/?code=C10AB02

41859-67-0 (English)

19 November 2016

0.6 gram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

bezafibrate (English)

1 reference

bezafibrate (English)

19 October 2016

bezafibratum (English)

1 reference

bezafibrate (English)

medical condition treated

19 October 2016

familial hyperlipidemia

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/Y9449Q51XH

2 November 2018

reference URL

http://www.medsafe.govt.nz/Consumers/CMI/b/bezalip.pdf

http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1441946173563.pdf

significant drug interaction

(S)-(−)-colchicine

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

atorvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

simvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pravastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-(−)-colchicine

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

simvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atorvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pravastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Peroxisome proliferator activated receptor alpha

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2668

InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)

17 August 2016

1 reference

Medical Subject Headings

15 March 2018

Bezafibrate

0 references

Identifiers

InChI

1 reference

IIBYAHWJQTYFKB-UHFFFAOYSA-N

41859-67-0 (English)

19 November 2016

2 references

41859-67-0 (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

41859-67-0

2 references

bezafibrate (English)

IIBYAHWJQTYFKB-UHFFFAOYSA-N

19 November 2016

InChIKey

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=41859-67-0

1 reference

Bezafibrate (English)

19 November 2016

1 reference

41859-67-0 (English)

19 November 2016

Reaxys registry number

4267656

1 reference

bezafibrate (English)

19 October 2016

ChEBI ID

47612

mapping relation type

1 reference

BEZAFIBRATE (English)

19 November 2016

1 reference

MSBNK-Athens_Univ-AU234157

BEZAFIBRATE (English)

19 November 2016

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Athens_Univ-AU234158

0 references

MSBNK-Athens_Univ-AU234159

0 references

MSBNK-Athens_Univ-AU234160

0 references

0 references

0 references

0 references

0 references

splash10-03di-0019000000-58ff2df39e2672d16d49

0 references

splash10-00n0-0945000000-47d515a6530eb8a46418

0 references

splash10-0079-0900000000-5b8c8d881ef997da896b

0 references

splash10-0079-0900000000-aee3a31283069d780fdf

0 references

splash10-0079-1900000000-673255bfbbfc965f4660

0 references

splash10-000i-2900000000-3dc6146a7815f02b2566

0 references

splash10-03di-0019000000-f9cec491196c09ca122d

0 references

splash10-00n0-0935000000-36d012b5f26656975242

0 references

splash10-0079-0900000000-c01b867af88dc70e482e

0 references

splash10-0079-0900000000-5d6c1954d400ba6b4b3a

0 references

splash10-0079-1900000000-8a719c7882b35ef9cb54

0 references

splash10-000i-2900000000-db13d869394c364ba607

0 references

splash10-016r-0049000000-27c256b6fd4b11f2a68a

0 references

splash10-00di-0090000000-ad4511ba17ddb3a6b528

0 references

splash10-03k9-0049000000-319540ed864d05b5a9e8

0 references

splash10-00di-0090000000-65fad146d0a2b8cc3aeb

0 references

splash10-0uk9-1980000000-f98f5d510895c2946e24

0 references

splash10-0udi-1900000000-58a247b2b13eaf401a8a

0 references

splash10-0udi-3900000000-82a7a949824b1efdbd18

0 references

splash10-03k9-0049000000-e56612834951c9281537

0 references

splash10-00di-0090000000-54280ef14ba8e69fb8fb

0 references

splash10-0fk9-1890000000-81049839e6d37ddb476a

0 references

splash10-0udi-0900000000-3ff4da4d943e21e1f3a1

0 references

splash10-0udi-2900000000-d499986dc5288dfff06c

0 references

splash10-00di-0090000000-62a3f94f91039648ffe1

0 references

splash10-0079-0900000000-a8a872a7835365dc4d41

0 references

splash10-0079-1900000000-30327ebb215c779dcc3f

0 references

splash10-016r-0049000000-23a7df2abaccf8e2ad58

0 references

splash10-014i-0039000000-c9963bd4cd1703531d68

0 references

splash10-00di-0390000000-52f95c54ab1946e7c69f

0 references

splash10-00di-0190000000-5257df29ed69050f426d

0 references

splash10-00di-0090000000-ced0d5dcc71914483b64

0 references

splash10-00di-0090000000-849460edc8b9e96e9749

0 references

splash10-0079-0913000000-a4eb50a87f9a6c722663

0 references

splash10-00di-2392000000-f4f98f4b89b6ae9a88d1

0 references

0 references

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

255-567-9

1 reference

bezafibrate (English)

ECHA Substance Infocard ID

19 November 2016

100.050.498

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.050.498

27 December 2018

AICS Chemical ID (BEING DELETED)

Bezafibrate (English)

quotation

CAS no.: 41859-67-0 (English)

0 references

1 reference

Guide to Pharmacology Ligand ID

Bezafibrate (English)

publication date

17 November 2015

2668

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2668

D02.241.081.114.968.500.249

bezafibrate (English)

19 November 2016

Bezafibrate

0 references

0 references

0 references

0 references

D02.241.223.100.100.120

0 references

D02.241.223.100.200.249

0 references

D02.355.726.305.249

0 references

D02.455.426.559.389.127.085.101

0 references

D02.455.426.559.389.127.250.249

0 references

D02.455.426.559.389.657.654.305.249

0 references

RxNorm ID

1525

1 reference

bezafibrate (English)

19 November 2016

1 reference

Bezafibrate (English)

Human Metabolome Database ID

19 November 2016

HMDB0015465

1 reference

based on heuristic

inferred from InChIKey

1 reference

bezafibrate (English)

19 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

Bezafibrate (English)

19 January 2016

0 references

1 reference

6 April 2020

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

1 reference

1IWH (English)